다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

KOSP

Kos (KOSP)

Kos Pharmaceuticals

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KOSP

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2006/12/13	23:22	PR Newswire (US)	Abbott Acquires a Majority of Shares of Kos Pharmaceuticals, Inc.	NASDAQ:KOSP	Kos Pharmaceuticals
2006/12/05	05:36	PR Newswire (US)	Abbott's Acquisition of Kos Pharmaceuticals, Inc. Clears Antitrust Review	NASDAQ:KOSP	Kos Pharmaceuticals
2006/11/15	03:45	PR Newswire (US)	Abbott Laboratories Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals, Inc.	NASDAQ:KOSP	Kos Pharmaceuticals
2006/11/09	21:00	Business Wire	Kos Reports a 17% Increase in Revenue, Earnings Per Share of $0.71, and Solid Cash Flow from Operations	NASDAQ:KOSP	Kos Pharmaceuticals
2006/11/08	01:21	PR Newswire (US)	Holland & Knight Leads Kos Pharmaceuticals, Inc. Buyout by Abbott Laboratories for $3.7 Billion	NASDAQ:KOSP	Kos Pharmaceuticals
2006/11/06	21:50	PR Newswire (US)	Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals	NASDAQ:KOSP	Kos Pharmaceuticals
2006/11/03	23:31	Business Wire	Kos to Report Third Quarter Results on November 9, 2006 Conference Call at 8:30 A.M. ET	NASDAQ:KOSP	Kos Pharmaceuticals
2006/09/22	05:41	Business Wire	Kos Announces Positive Overall Results for Two Phase III Trials of Icatibant for the Treatment of Hereditary Angioedema	NASDAQ:KOSP	Kos Pharmaceuticals
2006/09/19	20:00	Business Wire	Kos to Present at the UBS Global Life Sciences Conference	NASDAQ:KOSP	Kos Pharmaceuticals
2006/09/18	23:05	Business Wire	Kos Pharmaceuticals Announces Compliance with NASDAQ Continued Listing Requirements	NASDAQ:KOSP	Kos Pharmaceuticals
2006/09/06	21:30	PR Newswire (US)	SkyePharma and Mundipharma Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in Europe	NASDAQ:KOSP	Kos Pharmaceuticals
2006/08/17	05:15	Business Wire	Kos Announces Notice from Nasdaq Regarding Potential Delisting	NASDAQ:KOSP	Kos Pharmaceuticals
2006/08/10	01:42	PR Newswire (US)	Arisaph Pharmaceuticals Announces Second Closing of $8 Million Equity Investment	NASDAQ:KOSP	Kos Pharmaceuticals
2006/08/08	20:00	Business Wire	Kos Reports 25% Increase in Revenue, Solid Financial Results and Progress in Research and Development	NASDAQ:KOSP	Kos Pharmaceuticals
2006/07/27	23:26	Business Wire	Kos to Report Second Quarter Results on August 8, 2006 Conference Call at 8:30 a.m. ET	NASDAQ:KOSP	Kos Pharmaceuticals
2006/07/25	23:39	Business Wire	Kos Reports Summary Results from Clinical Study on Benefits of Combining Aspirin with Optimized Niaspan(R) CF	NASDAQ:KOSP	Kos Pharmaceuticals
2006/07/12	23:18	Business Wire	Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products	NASDAQ:KOSP	Kos Pharmaceuticals
2006/06/20	15:00	Business Wire	Niaspan(R) Combined with Low/Moderate Dosed Statin Achieves Better Total Lipid Control vs. Higher Dose Statin Monotherapy or Zo	NASDAQ:KOSP	Kos Pharmaceuticals
2006/06/07	22:42	Business Wire	Kos Announces Completion of Patient Randomization for Jerini's Phase III Clinical Trials of Icatibant for the Subcutaneous Trea	NASDAQ:KOSP	Kos Pharmaceuticals
2006/05/09	20:00	Business Wire	Kos Reports Continued Double Digit Increase in Revenue, Financial Results in Line with Guidance and Authorization for up to 7 M	NASDAQ:KOSP	Kos Pharmaceuticals
2006/05/08	21:00	PR Newswire (US)	SkyePharma and Kos to Host Teleconference Today on US Marketing and Distribution Agreement for Flutiform(TM)	NASDAQ:KOSP
2006/05/08	16:00	PR Newswire (US)	SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in the United States	NASDAQ:KOSP	Kos Pharmaceuticals
2006/05/05	23:51	Business Wire	CORRECTING and REPLACING Kos Announces Presentation at the Bank of America 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
2006/05/05	21:30	Business Wire	Kos Announces Presentation at the Bank of America 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
2006/04/26	02:09	Business Wire	Kos Announces Presentation at the Deutsche Bank 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
2006/04/25	06:06	Business Wire	Kos Pharmaceuticals to Report First Quarter Results on May 9, 2006 Conference Call at 8:30 A.M. ET	NASDAQ:KOSP	Kos Pharmaceuticals
2006/04/19	23:25	Business Wire	Kos Announces Annual Shareholders Meeting April 27, 2006	NASDAQ:KOSP	Kos Pharmaceuticals
2006/04/13	03:51	Business Wire	Centers for Medicare and Medicaid Services (CMS) Advises Plans Niaspan(R) is Now a Part D Eligible Drug; Confirms Niaspan as an	NASDAQ:KOSP	Kos Pharmaceuticals
2006/03/01	22:36	Business Wire	Kos Announces Presentation at the Lehman Brothers Ninth Annual Global Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
2006/02/28	22:52	Business Wire	Kos Announces Presentation at the SG Cowen 26th Annual Health Care Conference	NASDAQ:KOSP	Kos Pharmaceuticals

검색 관련기사 보기:NASDAQ:KOSP

1 2 3 다음 >>

Global Commodities Oppor...

ERShares NextGen Entrepr...

Ecora Resources (PK)

PagSeguro Digital

NLBNPIT22K89 20991231 17...

Kazakhtelecom (CE)

Bp Cap. 1.00%23

Bitwise Bitcoin and Ethe...

Crdit Agricole 4000% unt...

Realio Network USD Stablecoin

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관